Biotricity Inc
(BTCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,413 | -18,658 | -13,986 | -9,469 | -4,776 |
| Depreciation Amortization | 559 | 749 | 156 | 104 | 52 |
| Accounts receivable | -331 | 686 | -41 | -54 | 180 |
| Other Working Capital | 831 | 2,309 | 730 | -82 | 155 |
| Other Operating Activity | 522 | 1,366 | 1,471 | 1,010 | 351 |
| Operating Cash Flow | $-1,832 | $-13,548 | $-11,670 | $-8,490 | $-4,039 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 480 | 1,476 | 1,828 | N/A | N/A |
| Debt Issued | 856 | 2,355 | N/A | N/A | N/A |
| Common Stock Issued | 0 | 13 | 13 | 13 | 13 |
| Dividend Paid | -6 | -947 | -941 | -720 | -517 |
| Other Financing Activity | 0 | -896 | -896 | -399 | -329 |
| Financing Cash Flow | $1,329 | $2,002 | $4 | $-1,106 | $-833 |
| Exchange Rate Effect | -16 | 50 | 50 | 27 | 14 |
| Beginning Cash Position | 571 | 12,067 | 12,067 | 12,067 | 12,067 |
| End Cash Position | 51 | 571 | 451 | 2,498 | 7,208 |
| Net Cash Flow | $-519 | $-11,497 | $-11,616 | $-9,569 | $-4,859 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,832 | -13,548 | -11,670 | -8,490 | -4,039 |
| Free Cash Flow | -1,832 | -13,548 | -11,670 | -8,490 | -4,039 |